BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29720224)

  • 1. Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study.
    Chen BT; Sethi SK; Jin T; Patel SK; Ye N; Sun CL; Rockne RC; Haacke EM; Root JC; Saykin AJ; Ahles TA; Holodny AI; Prakash N; Mortimer J; Waisman J; Yuan Y; Somlo G; Li D; Yang R; Tan H; Katheria V; Morrison R; Hurria A
    Breast Cancer Res; 2018 May; 20(1):38. PubMed ID: 29720224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer.
    Chen BT; Jin T; Patel SK; Ye N; Sun CL; Ma H; Rockne RC; Root JC; Saykin AJ; Ahles TA; Holodny AI; Prakash N; Mortimer J; Waisman J; Yuan Y; Li D; Somlo G; Vazquez J; Levi A; Tan H; Yang R; Katheria V; Hurria A
    Breast Cancer Res Treat; 2018 Nov; 172(2):363-370. PubMed ID: 30088178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcortical brain iron deposition and cognitive performance in older women with breast cancer receiving adjuvant chemotherapy: A pilot MRI study.
    Chen BT; Ghassaban K; Jin T; Patel SK; Ye N; Sun CL; Kim H; Rockne RC; Mark Haacke E; Root JC; Saykin AJ; Ahles TA; Holodny AI; Prakash N; Mortimer J; Waisman J; Yuan Y; Somlo G; Li D; Yang R; Tan H; Katheria V; Morrison R; Hurria A
    Magn Reson Imaging; 2018 Dec; 54():218-224. PubMed ID: 30076946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic brain activity changes associated with adjuvant chemotherapy in older women with breast cancer: a pilot longitudinal study.
    Chen BT; Jin T; Patel SK; Ye N; Ma H; Wong CW; Rockne RC; Root JC; Saykin AJ; Ahles TA; Holodny AI; Prakash N; Mortimer J; Waisman J; Yuan Y; Li D; Sedrak MS; Vazquez J; Katheria V; Dale W
    Breast Cancer Res Treat; 2019 Jul; 176(1):181-189. PubMed ID: 30989462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.
    Hurria A; Rosen C; Hudis C; Zuckerman E; Panageas KS; Lachs MS; Witmer M; van Gorp WG; Fornier M; D'Andrea G; Moasser M; Dang C; Van Poznak C; Hurria A; Holland J
    J Am Geriatr Soc; 2006 Jun; 54(6):925-31. PubMed ID: 16776787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent brain volume and neuropsychological changes after chemotherapy in breast cancer patients.
    Blommaert J; Schroyen G; Vandenbulcke M; Radwan A; Smeets A; Peeters R; Sleurs C; Neven P; Wildiers H; Amant F; Sunaert S; Deprez S
    Hum Brain Mapp; 2019 Dec; 40(17):4994-5010. PubMed ID: 31436005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors.
    Kesler SR; Blayney DW
    JAMA Oncol; 2016 Feb; 2(2):185-92. PubMed ID: 26633037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical thinning in chemotherapy-treated older long-term breast cancer survivors.
    Daniel E; Deng F; Patel SK; Sedrak MS; Kim H; Razavi M; Sun CL; Root JC; Ahles TA; Dale W; Chen BT
    Brain Imaging Behav; 2023 Feb; 17(1):66-76. PubMed ID: 36369620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.
    Ahles TA; Saykin AJ; McDonald BC; Li Y; Furstenberg CT; Hanscom BS; Mulrooney TJ; Schwartz GN; Kaufman PA
    J Clin Oncol; 2010 Oct; 28(29):4434-40. PubMed ID: 20837957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
    Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
    J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal assessment of chemotherapy-induced alterations in brain activation during multitasking and its relation with cognitive complaints.
    Deprez S; Vandenbulcke M; Peeters R; Emsell L; Smeets A; Christiaens MR; Amant F; Sunaert S
    J Clin Oncol; 2014 Jul; 32(19):2031-8. PubMed ID: 24868029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.
    Janelsins MC; Heckler CE; Peppone LJ; Kamen C; Mustian KM; Mohile SG; Magnuson A; Kleckner IR; Guido JJ; Young KL; Conlin AK; Weiselberg LR; Mitchell JW; Ambrosone CA; Ahles TA; Morrow GR
    J Clin Oncol; 2017 Feb; 35(5):506-514. PubMed ID: 28029304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy-related cognitive impairment in patients with breast cancer based on MRS and DTI analysis.
    Tong T; Lu H; Zong J; Lv Q; Chu X
    Breast Cancer; 2020 Sep; 27(5):893-902. PubMed ID: 32301096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging.
    de Ruiter MB; Reneman L; Boogerd W; Veltman DJ; Caan M; Douaud G; Lavini C; Linn SC; Boven E; van Dam FS; Schagen SB
    Hum Brain Mapp; 2012 Dec; 33(12):2971-83. PubMed ID: 22095746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying Chemotherapy Delivery in Older and Younger Women With Early-Stage Breast Cancer Using Longitudinal Cumulative Dose.
    Pak J; Nyrop KA; Muss HB; Forster MK; Lund JL
    Oncologist; 2024 Apr; 29(4):311-315. PubMed ID: 38330406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study.
    Debess J; Riis JØ; Engebjerg MC; Ewertz M
    Breast Cancer Res Treat; 2010 May; 121(1):91-100. PubMed ID: 20306129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?
    Billiet T; Emsell L; Vandenbulcke M; Peeters R; Christiaens D; Leemans A; Van Hecke W; Smeets A; Amant F; Sunaert S; Deprez S
    Brain Imaging Behav; 2018 Feb; 12(1):64-77. PubMed ID: 28102529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study protocol of the Aerobic exercise and CogniTIVe functioning in women with breAsT cancEr (ACTIVATE) trial: a two-arm, two-centre randomized controlled trial.
    Brunet J; Barrett-Bernstein M; Zadravec K; Taljaard M; LeVasseur N; Srikanthan A; Bland KA; Collins B; Kam JWY; Handy TC; Hayden S; Simmons C; Smith AM; Virji-Babul N; Campbell KL
    BMC Cancer; 2020 Jul; 20(1):711. PubMed ID: 32736542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive effects of chemotherapy in breast cancer patients: a dose-response study.
    Collins B; MacKenzie J; Tasca GA; Scherling C; Smith A
    Psychooncology; 2013 Jul; 22(7):1517-27. PubMed ID: 22936651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.